Psychosis Research Today is a free monthly online journal that collates and summarizes the latest research about Psychosis, including details on clinical depression, schizophrenia, bipolar disorder.

Volume 1 (2005), Issue 9 (October)

1. Treatment of cognitive impairment in early psychosis: a comparison of risperidone and haloperidol in a large long-term trial.
   Am J Psychiatry, 162(10): 1888-95. [Abstract] [Full-text]
2. Cannabis use and misuse prevalence among people with psychosis.
   Br J Psychiatry, 187: 306-13. [Abstract] [Full-text]
3. The role of family work in early psychosis.
   Schizophr Res, 79(1): 77-83. [Abstract] [Full-text]
4. Impact of substance use on the onset and course of early psychosis.
   Schizophr Res, 79(1): 69-75. [Abstract] [Full-text]
5. What causes the onset of psychosis?
   Schizophr Res, 79(1): 23-34. [Abstract] [Full-text]
6. Integrated treatment ameliorates negative symptoms in first episode psychosis--results from the Danish OPUS trial.
   Schizophr Res, 79(1): 95-105. [Abstract] [Full-text]
7. Sustained attention in young people at high risk of psychosis does not predict transition to psychosis.
   Schizophr Res, 79(1): 127-36. [Abstract] [Full-text]
8. Clinical and genetic high-risk strategies in understanding vulnerability to psychosis.
   Schizophr Res, 79(1): 35-44. [Abstract] [Full-text]
9. Polymorphisms in the promoter region of the alpha1A-adrenoceptor gene are associated with schizophrenia/schizoaffective disorder in a Spanish isolate population.
   Biol Psychiatry, 58(6): 435-9. [Abstract] [Full-text]
10. The relationship between duration of untreated psychosis and outcome: an eight-year prospective study.
    Schizophr Res, 79(1): 85-93. [Abstract] [Full-text]
11. From dopamine to salience to psychosis--linking biology, pharmacology and phenomenology of psychosis.
    Schizophr Res, 79(1): 59-68. [Abstract] [Full-text]
12. Subjective quality of life in subjects at risk for a first episode of psychosis: a comparison with first episode schizophrenia patients and healthy controls.
    Schizophr Res, 79(1): 137-43. [Abstract] [Full-text]
13. Three-year outcome of family work in an early psychosis program.
    Schizophr Res, 79(1): 107-16. [Abstract] [Full-text]
14. Genomewide linkage scan in schizoaffective disorder: significant evidence for linkage at 1q42 close to DISC1, and suggestive evidence at 22q11 and 19p13.
    Arch Gen Psychiatry, 62(10): 1081-8. [Abstract] [Full-text]
15. Encountering touch: a path to affinity in psychiatric care.
    Issues Ment Health Nurs, 26(8): 843-52. [Abstract] [Full-text]
16. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.
    Clin Neurol Neurosurg, 107(6): 497-508. [Abstract] [Full-text]
17. Development and pilot testing of a new psychosocial intervention for older Latinos with chronic psychosis.
    Schizophr Bull, 31(4): 922-30. [Abstract] [Full-text]
18. If 'atypical' neuroleptics did not exist, it wouldn't be necessary to invent them: perverse incentives in drug development, research, marketing and clinical practice.
    Med Hypotheses, 65(6): 1005-9. [Abstract] [Full-text]
19. Is there evidence in the EEG for increased epileptiform activity in ICD-10 acute and transient psychotic disorder?
    Psychopathology, 38(5): 281-4. [Abstract] [Full-text]
20. Psychiatric complications in Parkinson disease.
    Am J Geriatr Psychiatry, 13(10): 844-51. [Abstract] [Full-text]
21. Deconstructing the familiality of the emotive component of psychotic experiences in the general population.
    Acta Psychiatr Scand, 112(5): 394-401. [Abstract] [Full-text]
22. A prospective study of offspring of women with psychosis: visual dysfunction in early childhood predicts schizophrenia-spectrum disorders in adulthood.
    Acta Psychiatr Scand, 112(5): 385-93. [Abstract] [Full-text]
23. Are apparent associations between parental representations and psychosis risk mediated by early trauma?
    Acta Psychiatr Scand, 112(5): 372-5. [Abstract] [Full-text]
24. Early trauma may increase the risk for psychotic experiences by impacting on emotional response and perception of control.
    Acta Psychiatr Scand, 112(5): 360-6. [Abstract] [Full-text]
25. Childhood trauma, psychosis and schizophrenia: a literature review with theoretical and clinical implications.
    Acta Psychiatr Scand, 112(5): 330-50. [Abstract] [Full-text]
26. Forced normalisation precipitated by lamotrigine.
    Seizure, 14(7): 485-9. [Abstract] [Full-text]
27. Factors associated with drug-induced visual hallucinations in Parkinson's disease.
    J Neurol, 252(10): 1223-8. [Abstract] [Full-text]
28. Hospital comorbidity bias and the concept of schizophrenia.
    Soc Psychiatry Psychiatr Epidemiol, 40(10): 817-21. [Abstract] [Full-text]
29. Pharmacological treatment for psychotic depression.
    Cochrane Database Syst Rev. [Abstract] [Full-text]
30. Benzodiazepines alone or in combination with antipsychotic drugs for acute psychosis.
    Cochrane Database Syst Rev. [Abstract] [Full-text]
31. Cortical glutamate-dopamine interaction and ketamine-induced psychotic symptoms in man.
    Psychopharmacology (Berl), 182(3): 375-83. [Abstract] [Full-text]
32. Understanding the genesis of psychotic disorder: issues in the prediction and prophylaxis of those at 'ultra-high risk'.
    Br J Clin Psychol, 44: 383-404. [Abstract] [Full-text]
33. Perceptions of psychosis, coping, appraisals, and psychological distress in the relatives of patients with schizophrenia: an exploration using self-regulation theory.
    Br J Clin Psychol, 44: 319-31. [Abstract] [Full-text]
34. Improvement of extrapyramidal symptoms following dehydroepiandrosterone (DHEA) administration in antipsychotic treated schizophrenia patients: a randomized, double-blind placebo controlled trial.
    Schizophr Res, 79(2): 251-6. [Abstract] [Full-text]
35. Cannabis--psychosis pathway independent of other types of psychopathology.
    Schizophr Res, 79(2): 289-95. [Abstract] [Full-text]
36. The underlying structure of diagnostic systems of schizophrenia: a comprehensive polydiagnostic approach.
    Schizophr Res, 79(2): 217-29. [Abstract] [Full-text]
37. Increased nicotine and cotinine levels in smokers with schizophrenia and schizoaffective disorder is not a metabolic effect.
    Schizophr Res, 79(2): 323-35. [Abstract] [Full-text]
38. Catechol-O-methyltransferase haplotypes are associated with psychosis in Alzheimer disease.
    Mol Psychiatry, 10(11): 1026-36. [Abstract] [Full-text]
39. Neuregulin-1 polymorphism in late onset Alzheimer's disease families with psychoses.
    Am J Med Genet B Neuropsychiatr Genet, 139(1): 28-32. [Abstract] [Full-text]
40. Vivid dreams, hallucinations, psychosis and REM sleep in Guillain-Barré syndrome.
    Brain, 128: 2535-45. [Abstract] [Full-text]
41. Novel brain reactive autoantibodies: prevalence in systemic lupus erythematosus and association with psychoses and seizures.
    J Neuroimmunol, 169(1): 153-60. [Abstract] [Full-text]

© 2005-2008 Psychosis Research Today. All Rights Reserved.